| Views | |
|---|---|
| Development of a transcutaneous form of desloratadine | 70 |
| October 2025 | November 2025 | December 2025 | January 2026 | February 2026 | March 2026 | April 2026 | |
|---|---|---|---|---|---|---|---|
| Development of a transcutaneous form of desloratadine | 12 | 3 | 0 | 2 | 9 | 4 | 0 |
| Views | |
|---|---|
| Ageev_Development_24.pdf | 54 |
| Views | |
|---|---|
| United States | 21 |
| Canada | 7 |
| China | 5 |
| Germany | 3 |
| EU | 3 |
| India | 3 |
| Russia | 2 |
| Australia | 1 |
| Brazil | 1 |
| Denmark | 1 |
| Views | |
|---|---|
| Mountain View | 9 |
| Ottawa | 7 |
| Beijing | 3 |
| Dearborn | 3 |
| Mumbai | 3 |
| Sacramento | 3 |
| Palo Alto | 2 |
| Amman | 1 |
| Darmstadt | 1 |
| Englewood | 1 |